Clinical trial
Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
NCT00025610 · European Infant Neuroblastoma Study Group - 1999, Other · Completed
Key facts
| NCT number | NCT00025610 |
|---|---|
| Title | Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma |
| Official title | European Infant Neuroblastoma Study - Stage 4S and Stage 4 (No Bone, Lung, Pleura or CNS); MYCN Not Amplified |
| Lead sponsor | European Infant Neuroblastoma Study Group - 1999, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Drug |
| Interventions | carboplatin, cyclophosphamide, doxorubicin hydrochloride, etoposide, vincristine sulfate |
| Start date | Jul 1, 1999 |
| Completion | Mar 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 17, 2013 |
| Countries | Austria, Belgium, Denmark, France, Italy, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: